Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.
Le Meur Y, Thierry A, Glowacki F, Rerolle JP, Garrigue V, Ouali N, Heng AE, Delahousse M, Albano L, Lang P, Couzi L, Jaureguy M, Lebranchu Y, Mousson C, Glotz D, Kessler M, Vrtovsnik F, Rouanet S, Tagieva N, Kamar N. Le Meur Y, et al. Transplantation. 2011 Dec 15;92(11):1244-51. doi: 10.1097/TP.0b013e318234e134. Transplantation. 2011. PMID: 22067312 Clinical Trial.
Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.
Lebranchu Y, Bridoux F, Büchler M, Le Meur Y, Etienne I, Toupance O, Hurault de Ligny B, Touchard G, Moulin B, Le Pogamp P, Reigneau O, Guignard M, Rifle G. Lebranchu Y, et al. Among authors: le pogamp p, le meur y. Am J Transplant. 2002 Jan;2(1):48-56. doi: 10.1034/j.1600-6143.2002.020109.x. Am J Transplant. 2002. PMID: 12095056 Free article. Clinical Trial.
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil.
Prémaud A, Debord J, Rousseau A, Le Meur Y, Toupance O, Lebranchu Y, Hoizey G, Le Guellec C, Marquet P. Prémaud A, et al. Among authors: le meur y, le guellec c. Clin Pharmacokinet. 2005;44(8):837-47. doi: 10.2165/00003088-200544080-00005. Clin Pharmacokinet. 2005. PMID: 16029068 Clinical Trial.
CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.
Abou-Ayache R, Büchler M, Lepogamp P, Westeel PF, Le Meur Y, Etienne I, Lobbedez T, Toupance O, Caillard S, Goujon JM, Bergougnoux L, Touchard G. Abou-Ayache R, et al. Among authors: le meur y. Nephrol Dial Transplant. 2008 Jun;23(6):2024-32. doi: 10.1093/ndt/gfm873. Epub 2008 Jan 16. Nephrol Dial Transplant. 2008. PMID: 18199693 Clinical Trial.
TCF7L2 polymorphism associates with new-onset diabetes after transplantation.
Ghisdal L, Baron C, Le Meur Y, Lionet A, Halimi JM, Rerolle JP, Glowacki F, Lebranchu Y, Drouet M, Noël C, El Housni H, Cochaux P, Wissing KM, Abramowicz D, Abramowicz M. Ghisdal L, et al. Among authors: le meur y. J Am Soc Nephrol. 2009 Nov;20(11):2459-67. doi: 10.1681/ASN.2008121314. Epub 2009 Aug 27. J Am Soc Nephrol. 2009. PMID: 19713311 Free PMC article.
242 results